• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2009年至2023年乌普萨拉大学医院的经导管主动脉瓣植入术:结果与时间趋势

Transcatheter aortic valve implantation in Uppsala University Hospital 2009-2023: outcomes and temporal trends.

作者信息

de Wilde Elisa, Olivetti Leonardo, James Stefan, Christersson Christina, Buccheri Sergio, Lindblom Rickard, Amin Azad, Sarno Giovanna

机构信息

Department of Medical Sciences, Uppsala University, Uppsala, Sweden.

Uppsala Clinical Research Center, Uppsala, Sweden.

出版信息

Ups J Med Sci. 2025 Feb 28;130. doi: 10.48101/ujms.v130.10999. eCollection 2025.

DOI:10.48101/ujms.v130.10999
PMID:40313690
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12045075/
Abstract

BACKGROUND

In recent years, transcatheter aortic valve implantation (TAVI) has rapidly emerged as a key treatment option for aortic stenosis. TAVI has been performed at Uppsala University Hospital since 2009. Data on TAVI procedures have been collected in a nation-wide all-comer registry, the Swedish Transcatheter Cardiac Intervention Registry (SWENTRY). However, only limited analysis has been conducted on trends in short- and long-term outcomes of TAVI patients in Sweden.

METHODS

This registry-based cohort study aims to evaluate outcome trends and long-term prognosis in patients who underwent TAVI in a Swedish single center between 2009 and 2023. Survival outcomes were studied using the Kaplan-Meier method. Cox Proportional Hazards models were used to adjust for differences in patient characteristics over time.

RESULTS

In total, 1,741 TAVI procedures were performed between 2009 and 2023. Immediate procedural mortality and 1-year mortality averaged at 0.9 and 8.1%, respectively. Both procedural and long-term mortality showed a decreasing trend over time. Similar results were observed when controlling for comorbidities and age.

CONCLUSIONS

Short-term outcomes and long-term prognosis have been constantly improving for patients undergoing TAVI within this study. Similar mortality and complication trends have been observed in other registry studies. These trends may be attributed to improvements in the quality of care, and the increased use of TAVI in lower risk patients.

摘要

背景

近年来,经导管主动脉瓣植入术(TAVI)已迅速成为主动脉瓣狭窄的关键治疗选择。自2009年以来,乌普萨拉大学医院一直在开展TAVI手术。TAVI手术的数据已收集在一个全国性的所有患者登记处,即瑞典经导管心脏介入登记处(SWENTRY)。然而,对于瑞典TAVI患者的短期和长期结局趋势,仅进行了有限的分析。

方法

这项基于登记处的队列研究旨在评估2009年至2023年期间在瑞典单一中心接受TAVI手术的患者的结局趋势和长期预后。使用Kaplan-Meier方法研究生存结局。采用Cox比例风险模型来调整患者特征随时间的差异。

结果

2009年至2023年期间共进行了1741例TAVI手术。手术即刻死亡率和1年死亡率平均分别为0.9%和8.1%。手术死亡率和长期死亡率均随时间呈下降趋势。在控制合并症和年龄时也观察到了类似结果。

结论

在本研究中,接受TAVI手术的患者短期结局和长期预后一直在不断改善。在其他登记处研究中也观察到了类似的死亡率和并发症趋势。这些趋势可能归因于护理质量的提高以及TAVI在低风险患者中的使用增加。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/acca/12045075/8fa5b4687e8e/UJMS-130-10999-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/acca/12045075/a73a694b4dec/UJMS-130-10999-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/acca/12045075/b57451035fa6/UJMS-130-10999-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/acca/12045075/bdaae8321298/UJMS-130-10999-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/acca/12045075/49aeda72327f/UJMS-130-10999-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/acca/12045075/8b2d7d2ffac7/UJMS-130-10999-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/acca/12045075/8fa5b4687e8e/UJMS-130-10999-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/acca/12045075/a73a694b4dec/UJMS-130-10999-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/acca/12045075/b57451035fa6/UJMS-130-10999-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/acca/12045075/bdaae8321298/UJMS-130-10999-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/acca/12045075/49aeda72327f/UJMS-130-10999-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/acca/12045075/8b2d7d2ffac7/UJMS-130-10999-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/acca/12045075/8fa5b4687e8e/UJMS-130-10999-g006.jpg

相似文献

1
Transcatheter aortic valve implantation in Uppsala University Hospital 2009-2023: outcomes and temporal trends.2009年至2023年乌普萨拉大学医院的经导管主动脉瓣植入术:结果与时间趋势
Ups J Med Sci. 2025 Feb 28;130. doi: 10.48101/ujms.v130.10999. eCollection 2025.
2
Five-year follow-up after transcatheter aortic valve implantation for symptomatic aortic stenosis.症状性主动脉瓣狭窄经导管主动脉瓣植入术后的五年随访
Heart. 2017 Dec;103(24):1970-1976. doi: 10.1136/heartjnl-2016-311004. Epub 2017 Jul 6.
3
In-hospital and mid-term predictors of mortality after transcatheter aortic valve implantation: data from the TAVI National Registry 2010-2011.经导管主动脉瓣植入术后院内及中期死亡预测因素:来自2010 - 2011年经导管主动脉瓣植入术国家注册研究的数据
Rev Esp Cardiol (Engl Ed). 2013 Dec;66(12):949-58. doi: 10.1016/j.rec.2013.07.003. Epub 2013 Oct 4.
4
Pre-procedural CT angiography inferior vena cava measurements: a predictor of mortality in patients undergoing transcatheter aortic valve implantation.经导管主动脉瓣植入术前 CT 血管造影下腔静脉测量:预测患者死亡率的指标。
Eur Radiol. 2019 Feb;29(2):975-984. doi: 10.1007/s00330-018-5613-x. Epub 2018 Jul 17.
5
Regional assessment of availability for transcatheter aortic valve implantation in Sweden: a long-term observational study.瑞典经导管主动脉瓣植入术可及性的区域评估:一项长期观察性研究。
Eur Heart J Qual Care Clin Outcomes. 2024 Nov 5;10(7):641-649. doi: 10.1093/ehjqcco/qcad076.
6
Association between valvuloarterial impedance after transcatheter aortic valve implantation and 2-year mortality in elderly patients with severe symptomatic aortic stenosis: the OCEAN-TAVI registry.经导管主动脉瓣植入术后瓣膜动脉阻抗与老年重度症状性主动脉瓣狭窄患者2年死亡率之间的关联:OCEAN-TAVI注册研究
Heart Vessels. 2019 Jun;34(6):1031-1039. doi: 10.1007/s00380-018-01329-2. Epub 2019 Jan 1.
7
Temporal Trends in Transcatheter Aortic Valve Replacement in France: FRANCE 2 to FRANCE TAVI.法国经导管主动脉瓣置换术的时间趋势:FRANCE 2 至 FRANCE TAVI。
J Am Coll Cardiol. 2017 Jul 4;70(1):42-55. doi: 10.1016/j.jacc.2017.04.053.
8
Transcatheter aortic valve implantation in the United Kingdom: temporal trends, predictors of outcome, and 6-year follow-up: a report from the UK Transcatheter Aortic Valve Implantation (TAVI) Registry, 2007 to 2012.英国经导管主动脉瓣植入术:时间趋势、结局预测因素和 6 年随访:来自英国经导管主动脉瓣植入术(TAVI)登记处的报告,2007 年至 2012 年。
Circulation. 2015 Mar 31;131(13):1181-90. doi: 10.1161/CIRCULATIONAHA.114.013947. Epub 2015 Jan 30.
9
Relative Survival After Transcatheter Aortic Valve Implantation: How Do Patients Undergoing Transcatheter Aortic Valve Implantation Fare Relative to the General Population?经导管主动脉瓣置换术后的相对生存率:行经导管主动脉瓣置换术的患者与普通人群相比预后如何?
J Am Heart Assoc. 2017 Oct 17;6(10):e007229. doi: 10.1161/JAHA.117.007229.
10
Computed tomography predictors of mortality, stroke and conduction disturbances in women undergoing TAVR: A sub-analysis of the WIN-TAVI registry.经导管主动脉瓣置换术患者死亡率、卒中和传导障碍的计算机断层扫描预测因素:WIN-TAVI 注册研究的亚分析。
J Cardiovasc Comput Tomogr. 2018 Jul-Aug;12(4):338-343. doi: 10.1016/j.jcct.2018.04.007. Epub 2018 Apr 27.

本文引用的文献

1
Temporal trends of TAVI treatment characteristics in high volume centers in Germany 2013-2020.2013-2020 年德国大容量中心 TAVI 治疗特征的时间趋势。
Clin Res Cardiol. 2022 Aug;111(8):881-888. doi: 10.1007/s00392-021-01963-3. Epub 2021 Nov 9.
2
2021 ESC/EACTS Guidelines for the management of valvular heart disease.2021年欧洲心脏病学会/欧洲心胸外科学会瓣膜性心脏病管理指南。
Eur Heart J. 2022 Feb 12;43(7):561-632. doi: 10.1093/eurheartj/ehab395.
3
STS-ACC TVT Registry of Transcatheter Aortic Valve Replacement.经导管主动脉瓣置换术的STS-ACC TVT注册研究
J Am Coll Cardiol. 2020 Nov 24;76(21):2492-2516. doi: 10.1016/j.jacc.2020.09.595.
4
Infective endocarditis after transcatheter aortic valve implantation: a nationwide study.经导管主动脉瓣植入术后感染性心内膜炎:一项全国性研究。
Eur Heart J. 2019 Oct 14;40(39):3263-3269. doi: 10.1093/eurheartj/ehz588.
5
Predictors of early mortality after transcatheter aortic valve implantation.经导管主动脉瓣植入术后早期死亡的预测因素。
Open Heart. 2019 Apr 23;6(1):e000936. doi: 10.1136/openhrt-2018-000936. eCollection 2019.
6
Transcatheter Aortic-Valve Replacement with a Balloon-Expandable Valve in Low-Risk Patients.经皮球囊扩张式主动脉瓣置换术治疗低危患者。
N Engl J Med. 2019 May 2;380(18):1695-1705. doi: 10.1056/NEJMoa1814052. Epub 2019 Mar 16.
7
Transcatheter Aortic-Valve Replacement with a Self-Expanding Valve in Low-Risk Patients.经导管主动脉瓣置换术治疗低危患者的自膨式瓣膜。
N Engl J Med. 2019 May 2;380(18):1706-1715. doi: 10.1056/NEJMoa1816885. Epub 2019 Mar 16.
8
Five-Year Clinical and Echocardiographic Outcomes From the NOTION Randomized Clinical Trial in Patients at Lower Surgical Risk.NOTION 低手术风险患者随机临床试验的五年临床和超声心动图结果
Circulation. 2019 Jun 11;139(24):2714-2723. doi: 10.1161/CIRCULATIONAHA.118.036606. Epub 2019 Feb 1.
9
The impact of frailty on mortality after transcatheter aortic valve replacement.衰弱对经导管主动脉瓣置换术后死亡率的影响。
Ann Transl Med. 2017 Mar;5(6):144. doi: 10.21037/atm.2017.01.35.
10
Surgical or Transcatheter Aortic-Valve Replacement in Intermediate-Risk Patients.中危患者的外科手术或经导管主动脉瓣置换术。
N Engl J Med. 2017 Apr 6;376(14):1321-1331. doi: 10.1056/NEJMoa1700456. Epub 2017 Mar 17.